These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9341939)
1. bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Newcomb EW; Bhalla SK; Parrish CL; Hayes RL; Cohen H; Miller DC Acta Neuropathol; 1997 Oct; 94(4):369-75. PubMed ID: 9341939 [TBL] [Abstract][Full Text] [Related]
2. Role of gemistocytes in astrocytoma progression. Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival. Ehrmann J; Kolár Z; Vojtĕsek B; Kala M; Komenda S; Oulton A Neoplasma; 1997; 44(5):299-304. PubMed ID: 9473789 [TBL] [Abstract][Full Text] [Related]
4. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. Varela M; Ranuncolo SM; Morand A; Lastiri J; De Kier Joffé EB; Puricelli LI; Pallotta MG J Surg Oncol; 2004 Apr; 86(1):34-40. PubMed ID: 15048678 [TBL] [Abstract][Full Text] [Related]
5. Expression of Bcl-2, Bcl-x, and Bax proteins in astrocytomas in relation to patient survival. Daido S; Tamiya T; Ono Y; Terada K; Mizumatsu S; Ohmoto T Brain Tumor Pathol; 2001; 18(2):123-9. PubMed ID: 11908868 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors. Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373 [TBL] [Abstract][Full Text] [Related]
7. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival. Korkolopoulou P; Kouzelis K; Christodoulou P; Papanikolaou A; Thomas-Tsagli E Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754 [TBL] [Abstract][Full Text] [Related]
8. TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme. Kraus JA; Wenghoefer M; Glesmann N; Mohr S; Beck M; Schmidt MC; Schröder R; Berweiler U; Roggendorf W; Diete S; Dietzmann K; Heuser K; Müller B; Fimmers R; von Deimling A; Schlegel U J Neurooncol; 2001 May; 52(3):263-72. PubMed ID: 11519857 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression. Ono Y; Tamiya T; Ichikawa T; Matsumoto K; Furuta T; Ohmoto T; Akiyama K; Seki S; Ueki K; Louis DN Acta Neuropathol; 1997 Jul; 94(1):21-7. PubMed ID: 9224526 [TBL] [Abstract][Full Text] [Related]
10. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140 [TBL] [Abstract][Full Text] [Related]
11. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma. Shwetha SD; Shastry AH; Arivazhagan A; Santosh V Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112 [TBL] [Abstract][Full Text] [Related]
12. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas]. Yu S; Pu P; Jiang D; An T; Guan X; Yang L Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884 [TBL] [Abstract][Full Text] [Related]
13. Genetic sub-types of human malignant astrocytoma correlate with survival. Leenstra S; Oskam NT; Bijleveld EH; Bosch DA; Troost D; Hulsebos TJ Int J Cancer; 1998 Apr; 79(2):159-65. PubMed ID: 9583731 [TBL] [Abstract][Full Text] [Related]
14. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609 [TBL] [Abstract][Full Text] [Related]
15. Bcl-2 expression in higher-grade human glioma: a clinical and experimental study. Fels C; Schäfer C; Hüppe B; Bahn H; Heidecke V; Kramm CM; Lautenschläger C; Rainov NG J Neurooncol; 2000 Jul; 48(3):207-16. PubMed ID: 11100818 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063 [TBL] [Abstract][Full Text] [Related]
17. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay. Ishii N; Sawamura Y; Tada M; Daub DM; Janzer RC; Meagher-Villemure M; de Tribolet N; Van Meir EG Int J Cancer; 1998 Jun; 76(6):797-800. PubMed ID: 9626343 [TBL] [Abstract][Full Text] [Related]
18. p53 immunoreactivity in astrocytomas and its relationship to survival. al-Sarraj S; Bridges LR Br J Neurosurg; 1995 Apr; 9(2):143-9. PubMed ID: 7632359 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Ellison DW; Steart PV; Gatter KC; Weller RO Neuropathol Appl Neurobiol; 1995 Aug; 21(4):352-61. PubMed ID: 7494604 [TBL] [Abstract][Full Text] [Related]
20. Human gliomas with wild-type p53 express bcl-2. Alderson LM; Castleberg RL; Harsh GR; Louis DN; Henson JW Cancer Res; 1995 Mar; 55(5):999-1001. PubMed ID: 7867012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]